Optimizing mAb purification using a guard column
What are the benefits of introducing multimodal ion exchange chromatography as a guard column and [...]
Bio-Works increased customer base by 125 % during 2018
Press release February 7, 2019 Bio-Works had 236 active customers at the end of 2018. [...]
How to recognize an efficient protein A resin for mAbs
In short, an efficient protein A resin is one that will not only help you [...]
Three market changes that will impact the production of mAbs
In 2015, the monoclonal antibodies (mAbs) market was estimated to be USD 85,4 billion and [...]
How pure is pure? Controlling your mAb purification process
Monoclonal antibodies, mAbs, form a well-established, technologically advanced segment of the pharmaceutical industry offering hope [...]
WorkBeads affimAb launched
Bio-Works launches WorkBeads affimAb, a novel affinity resin designed for the purification of next-generation biological pharmaceuticals.
Bio-Works increases target for the number of new customers 2018
Bio-Works raises its new customer target for 2018, reflecting strong commercial momentum and growing market demand.
Bio-Works forms distinguished Scientific Advisory Board
Bio-Works establishes a Scientific Advisory Board of leading experts to guide its research and product development strategy.
WorkBeads used for full scale production of FDA approved drug
Bio-Works' WorkBeads resins are used in full-scale commercial production of an FDA-approved biopharmaceutical, validating the product's quality and reliability.
Bio-Works opens sales office in USA
Press release March 20th 2018 Bio-Works has opened a sales office in Philadelpia, USA to [...]
